Poor outcome associated with symptomatic deterioration among help-seeking individuals at risk for psychosis: A naturalistic follow-up study

Early Intervention in Psychiatry

Volumn 8, Issue 1, 2014, Pages 24-31

  Morita, Keiko ^a   Kobayashi, Hiroyuki ^b   Takeshi, Kiyoaki ^a   Tsujino, Naohisa ^a   Nemoto, Takahiro ^a   Mizuno, Masafumi ^a  

^a TOHO UNIVERSITY   (Japan)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

At risk mental states; Early intervention; Prodrome; Psychosis; Quality of life

Indexed keywords

ADULT; ARTICLE; AWARENESS; CLINICAL ARTICLE; FEMALE; FOLLOW UP; GLOBAL ASSESSMENT OF FUNCTIONING; HELP SEEKING BEHAVIOR; HUMAN; HUMAN RELATION; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEGATIVE SYNDROME; OUTPATIENT; POSITIVE SYNDROME; PRIORITY JOURNAL; PSYCHOSIS; QUALITY OF LIFE; SCALE TO ASSESS UNAWARENESS OF MENTAL DISORDER; SCALES OF PRODROMAL SYMPTOM; SOCIAL FUNCTIONING SCALE; SOCIAL INTERACTION; SUBJECTIVE WELLBEING UNDER NEUROLEPTIC; WELLBEING; WORLD HEALTH ORGANIZATION QUALITY OF LIFE 26;

AT-RISK MENTAL STATES; EARLY INTERVENTION; PRODROME; PSYCHOSIS; QUALITY OF LIFE;

ADOLESCENT; ADULT; DISEASE SUSCEPTIBILITY; EARLY MEDICAL INTERVENTION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PATIENT ACCEPTANCE OF HEALTH CARE; PRODROMAL SYMPTOMS; PSYCHOTHERAPY; PSYCHOTIC DISORDERS; PSYCHOTROPIC DRUGS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84897573399     PISSN: 17517885     EISSN: 17517893     Source Type: Journal    
DOI: 10.1111/eip.12032     Document Type: Article

References (31)

1. Bird V, Premkumar P, Kendall T, Whittington C, Mitchell J, Kuipers E. Early intervention services, cognitive-behavioural therapy and family intervention in early psychosis: systematic review. Br J Psychiatry 2010; 197: 350-356.
2. Preti A, Cella M. Randomized-controlled trials in people at ultra high risk of psychosis: a review of treatment effectiveness. Schizophr Res 2010; 123: 30-36.
3. Marshall M, Rathbone J. Early intervention for psychosis. Cochrane Database Syst Rev 2011; 15 (6): CD004718.
4. Hanssen M, Bak M, Bijl R, Vollebergh W, van Os J. The incidence and outcome of subclinical psychotic experiences in the general population. Br J Clin Psychol 2005; 44: 181-191.
5. Dominguez M, Wichers M, Lieb R, Wittchen H. Evidence that onset of clinical psychosis is an outcome of progressively more persistent subclinical psychotic experiences: an 8-year cohort study. Schizophr Bull 2011; 37: 84-93.
6. van Os J, Linscott RJ, Myin-Germeys I, Delespaul P, Krabbendam L. A systematic review and meta-analysis of the psychosis continuum: evidence for psychosis proneness-persistence-impairment model of psychotic disorder. Psychol Med 2009; 39: 179-195.
7. Kobayashi H, Nemoto T, Murakami M, Kashima H, Mizuno M. Lack of association between psychosis-like experiences and seeking help from professionals: a case-controlled study. Schizophr Res 2011; 132 (2-3): 208-212.
8. Simon AE, Velthorst E, Nieman DH, Linszen D, Umbricht D, de Haan L. Ultra high-risk state for psychosis and non-transition: a systematic review. Schizophr Res 2011; 132: 8-17.
9. Haroun N, Dunn L, Haroun A, Cadenhead KS. Risk and protection in prodromal schizophrenia: ethical implications for clinical practice and future research. Schizophr Bull 2006; 32: 166-178.
10. Yung AR, Stanford C, Cosgrave E etal. Testing the ultra high risk (prodromal) criteria for the prediction of psychosis in a clinical sample of young people. Schizophr Res 2006; 84: 57-66.
11. Addington J, Cornblatt BA, Cadenhead KS etal. At clinical high risk for psychosis: outcome for nonconverters. Am J Psychiatry 2011; 168: 800-805.
12. Yung AR, Phillips LJ, Nelson B etal. Randomized controlled trial of interventions for young people at ultra high risk for psychosis: 6-month analysis. J Clin Psychiatry 2011; 72: 430-440.
13. Miller TJ, McGlashan TH, Rosen JL etal. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr Bull 2003; 29: 703-715.
14. Kobayashi H, Nozaki S, Mizuno M. Reliability of the Structured Interview for Prodromal Syndromes Japanese version (SIPS-J). Jpn Soc Psychiat 2006; 15: 168-174. (Japanese).
15. Naber D. A self-rating to measure subjective effects of neuroleptic drugs. Relationships to objective psychopathology, quality of life, compliance and other clinical variables. Int Clin Psychopharmacol 1995; 10: 133-138.
16. Watanabe M, Matsumura H. Reliability and validity of Subjective Well-being under Neuroleptic drug treatment Short form, Japanese version (SWNS-J). Jpn J Clin Psychopharmacol 2003; 6: 905-912. (Japanese).
17. Amador XF, Strauss DH, Yale SA, Flaum MM, Endicott J, Gorman JM. Assessment of insight in psychosis. Am J Psychiatry 1993; 150: 873-879.
18. International Early Psychosis Association Writing Group. International clinical practice guidelines for early psychosis. Br J Psychiatry Suppl 2005; 48: s120-124.
19. Francey SM, Nelson B, Thompson A etal. Who needs antipsychotic medication in the earliest stages of psychosis? A reconsideration of benefits, risks, neurobiology and ethics in the era of early intervention. Schizophr Res 2010; 119 (1-3): 1-10.
20. de Koning MB, Bloemen OJ, van Amelsvoort TA etal. Early intervention in patients at ultra high risk of psychosis: benefits and risks. Acta Psychiatr Scand 2009; 119: 426-442.
21. Cornblatt BA, Lencz T, Smith CW etal. Can antidepressants be used to treat the schizophrenia prodrome? Results of a prospective, naturalistic treatment study of adolescents. J Clin Psychiatry 2007; 68: 546-557.
22. Cannon T, Cadenhead K, Cornblatt B etal. Prediction of psychosis in ultra high risk youth: a multi-site longitudinal study in North America. Arch Gen Psychiatry 2008; 65: 28-35.
23. Tor PC, Lee HY. Comparison of attitudes of psychiatrists vs primary healthcare physicians in Singapore towards At Risk Mental States (ARMS). Ann Acad Med Singapore 2009; 38: 442-446.
24. Tsujino N, Katagiri N, Kobayashi H, Netmoto T, Mizuno M. Recognition and decisions regarding the treatment of early psychosis by Japanese psychiatrists. Clin. Psychiatry 2010; 52: 1151-1159. (Japanese).
25. Chen EY, Dunn EL, Miao MY etal. The impact of family experience on the duration of untreated psychosis (DUP) in Hong Kong. Soc Psychiatry Psychiatr Epidemiol 2005; 40: 350-356.
26. Esterbeg M, Compton M. Family history of psychosis negatively impacts age at onset, negative symptoms, and duration of untreated illness and psychosis in first-episode psychosis patients. Psychiatry Res 2012; 197: 23-28.
27. Norman RMG, Malla AK, Manchanda R. Delay in treatment for psychosis: its relation to family history. Soc Psychiatry Psychiatr Epidemiol 2007; 42: 507-512.
28. Cotton SM, Lambert M, Schimmelmann BG etal. Gender differences in premorbid, entry, treatment, and outcome characteristics in a treated epidemiological sample of 661 patients with first episode psychosis. Schizophr Res 2009; 114: 17-24.
29. Chang WC, Tang JY, Hui CL etal. Gender differences in patients presenting with first-episode psychosis in Hong Kong: a three-year follow up study. Aust N Z J Psychiatry 2011; 45: 199-205.
30. Lin A, Wood SJ, Nelson B etal. Neurocognitive predictors of functional outcome two to 13 years after identification as ultra-high risk for psychosis. Schizophr Res 2011; 132: 1-7.
31. Schlosser DA, Jacobson S, Chen Q etal. Recovery from an at-risk state: clinical and functional outcomes of putatively prodromal youth who do not develop psychosis. Schizophr Bull 2012; 38: 1225-1233.